Concepedia

Xiaoyan Chu

XC

64

Publications

4.1K

Citations

38

H-Index

1997

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Washington

Gilead Sciences (United States)

The University of Tokyo

Biogen (United States)

Xiaoyan Chu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

1997–2024

64

Publications

64

Function and Expression of Multidrug Resistance-Associated Protein Family in Human Colon Adenocarcinoma Cells (Caco-2)

Tomoko Hirohashi, Hiroshi Suzuki, Xiaoyan Chu et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 192 citations

Interspecies Variability in Expression of Hepatobiliary Transporters across Human, Dog, Monkey, and Rat as Determined by Quantitative Proteomics

Li Wang, Bhagwat Prasad, Laurent Salphati et al. · Drug Metabolism and Disposition · 2014 · 187 citations

Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein

Xiaoyan Chu, Kelly Bleasby, Jocelyn Yabut et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 175 citations

Multispecific Organic Anion Transporter Is Responsible for the Biliary Excretion of the Camptothecin Derivative Irinotecan and its Metabolites in Rats

Xiaoyan Chu, Yukio Kato, Kayoko Niinuma et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 163 citations · Full text

Pitavastatin is a more sensitive and selective organic anion‐transporting polypeptide<scp>1B</scp>clinical probe than rosuvastatin

Thomayant Prueksaritanont, Xiaoyan Chu, Raymond Evers et al. · British Journal of Clinical Pharmacology · 2014 · 162 citations · Full text

Rows per page

1–5 of 64